Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review
Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review
About this item
Full title
Author / Creator
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Summary
2018 was the year of the first marketing authorization of an allogeneic stem cell therapy by the European Medicines Agency. The authorization concerns the use of allogeneic adipose tissue‐derived mesenchymal stromal cells (MSCs) for treatment of complex perianal fistulas in Crohn's disease. This is a breakthrough in the field of MSC ther...
Alternative Titles
Full title
Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ae4c0f6b1d2d48eaa4d774369996a0f7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ae4c0f6b1d2d48eaa4d774369996a0f7
Other Identifiers
ISSN
2157-6564
E-ISSN
2157-6580
DOI
10.1002/sctm.19-0073
